|
SLC30A7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.72800004597462E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.27240000150175E-08 |
| Normal-vs-Stage2 |
6.582600E-03 |
| Normal-vs-Stage3 |
1.580060E-03 |
| Normal-vs-Stage4 |
5.443900E-04 |
| Stage1-vs-Stage2 |
5.798000E-01 |
| Stage1-vs-Stage3 |
9.645000E-01 |
| Stage1-vs-Stage4 |
4.774200E-01 |
| Stage2-vs-Stage3 |
6.064000E-01 |
| Stage2-vs-Stage4 |
3.823800E-01 |
| Stage3-vs-Stage4 |
6.545000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.26419999310923E-09 |
| Normal-vs-AfricanAmerican |
1.063980E-01 |
| Normal-vs-Asian |
2.789900E-02 |
| Caucasian-vs-AfricanAmerican |
1.139930E-03 |
| Caucasian-vs-Asian |
2.035200E-01 |
| AfricanAmerican-vs-Asian |
5.576000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.13280000005422E-06 |
| Normal-vs-Female |
3.46939998951967E-09 |
| Male-vs-Female |
1.286370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.114400E-02 |
| Normal-vs-Age(41-60Yrs) |
9.38619999502066E-08 |
| Normal-vs-Age(61-80Yrs) |
2.73890000002108E-06 |
| Normal-vs-Age(81-100Yrs) |
6.086200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.079600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.886200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.469800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.691200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.349400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.238000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.036300E-03 |
| Normal-vs-Grade 2 |
7.39109999869925E-08 |
| Normal-vs-Grade 3 |
1.27729999999104E-06 |
| Normal-vs-Grade 4 |
7.781700E-03 |
| Grade 1-vs-Grade 2 |
4.487800E-01 |
| Grade 1-vs-Grade 3 |
6.037600E-01 |
| Grade 1-vs-Grade 4 |
3.341200E-01 |
| Grade 2-vs-Grade 3 |
3.532200E-02 |
| Grade 2-vs-Grade 4 |
3.651500E-02 |
| Grade 3-vs-Grade 4 |
5.592200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.80049974929375E-10 |
| Normal-vs-ccB subtype |
2.414600E-04 |
| ccA subtype-vs-ccB subtype |
9.884400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.94709999526921E-08 |
| Normal-vs-N1 |
7.922300E-02 |
| N0-vs-N1 |
8.509200E-01 |
|
|
